ArticleBritish journal of haematology2022

Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma.

Ewa Paszkiewicz-Kozik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.